A direct signaling pathway through tyrosine kinase activation of SH2 domain-containing transcription factors
- PMID: 7722410
- DOI: 10.1002/jlb.57.4.529
A direct signaling pathway through tyrosine kinase activation of SH2 domain-containing transcription factors
Abstract
Studies on the mechanism of interferon-induced gene expression revealed a direct signaling pathway from cell surface receptors to transcription factors. In this pathway, signal transduction is mediated by a new class of transcription factor STAT (signal transducer and activator of transcription). We have shown that STAT factors contain Src homology region 2 and 3 domains and are phosporylated and activated in the cytoplasm by receptor associated tyrosine kinases. The activated transcription factors then translocate to the nucleus, joined by a nuclear DNA binding factor, to form an active transcriptional complex. Recent studies have shown that this direct signaling pathway is the key to control of gene expression induced by many cytokines and growth factors.
Similar articles
-
A mutant signal transducer and activator of transcription 5b, associated with growth hormone insensitivity and insulin-like growth factor-I deficiency, cannot function as a signal transducer or transcription factor.J Clin Endocrinol Metab. 2006 Apr;91(4):1526-34. doi: 10.1210/jc.2005-2558. Epub 2006 Feb 7. J Clin Endocrinol Metab. 2006. PMID: 16464942
-
The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.Oncogene. 2000 Sep 28;19(41):4795-801. doi: 10.1038/sj.onc.1203829. Oncogene. 2000. PMID: 11032030
-
Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs.Nature. 1992 Mar 5;356(6364):71-4. doi: 10.1038/356071a0. Nature. 1992. PMID: 1531699
-
The p60c-src family of protein-tyrosine kinases: structure, regulation, and function.Crit Rev Oncog. 1992;3(4):401-46. Crit Rev Oncog. 1992. PMID: 1384720 Review.
-
IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled.Oncogene. 2000 May 15;19(21):2532-47. doi: 10.1038/sj.onc.1203594. Oncogene. 2000. PMID: 10851052 Review.
Cited by
-
Are All Janus Kinase Inhibitors for Inflammatory Bowel Disease the Same?Gastroenterol Hepatol (N Y). 2023 Dec;19(12):727-738. Gastroenterol Hepatol (N Y). 2023. PMID: 38404416 Free PMC article.
-
UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity.EMBO J. 2006 Jun 7;25(11):2358-67. doi: 10.1038/sj.emboj.7601149. Epub 2006 May 18. EMBO J. 2006. PMID: 16710296 Free PMC article.
-
Identification and functional characterization of a second chain of the interleukin-10 receptor complex.EMBO J. 1997 Oct 1;16(19):5894-903. doi: 10.1093/emboj/16.19.5894. EMBO J. 1997. PMID: 9312047 Free PMC article.
-
The JAK/STAT signaling pathway: from bench to clinic.Signal Transduct Target Ther. 2021 Nov 26;6(1):402. doi: 10.1038/s41392-021-00791-1. Signal Transduct Target Ther. 2021. PMID: 34824210 Free PMC article. Review.
-
A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation.J Virol. 2002 Jan;76(2):569-81. doi: 10.1128/jvi.76.2.569-581.2002. J Virol. 2002. PMID: 11752148 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous